Terminology - Nuvaxovid in Value Sets ergänzen (Annatina Foppa, eHealth Suisse)

[ig-feedback]

ch.fhir.ig.ch-vacd#2.0.0 /terminology.html

Mit Nuvaxovid steht ein protein-basierter Impfstoff zur Verfügung. => muss in Swissmedic-Liste, in Adverse-Reaction und allenfalls auch in weiteren Value Sets angepasst werden (zu überprüfen)

Annatina Foppa, eHealth Suisse

[annatinafoppa]

Thanks, but the according value has to be added in other value sets as well:

• SNOMED CT vaccines 1162643001 Vaccine product containing only severe acute respiratory syndrome coronavirus 2 recombinant spike protein antigen (medicinal product)
• Allergy 1162644007 Adverse reaction to component of vaccine product containing only severe acute respiratory syndrome coronavirus 2 recombinant spike protein antigen (disorder)
• Swiss Vaccination Plan Immunizations 1162645008 Administration of vaccine product containing only severe acute respiratory syndrome coronavirus 2 recombinant spike protein antigen (procedure)

[ralych]

@annatinafoppa wie sieht es mit den translations dafür aus?

[annatinafoppa]

covered by https://github.com/hl7ch/ch-vacd/issues/126